News & Press Releases

Filter
387 found

MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases

29 Jan 2019
R&D, Open source

Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine

16 Jan 2019
R&D

Professor Michael Ferguson receives Knighthood in New Year’s Honours List

14 Jan 2019
R&D

2018 - A triumph of partnerships

19 Dec 2018
General

Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria

07 Dec 2018
R&D

Access to Medicines Index highlights role of collaboration in stimulating R&D

21 Nov 2018
R&D, Access & product management

World Malaria Report highlights importance of country-led efforts to defeat malaria in highest burden countries

19 Nov 2018
General

Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO

19 Nov 2018
Partner, Access & product management

Ray Chambers appointed WHO Ambassador for Global Strategy

31 Oct 2018
General

Professor James McCarthy elected Fellow of Australian Academy of Health and Medical Sciences

31 Oct 2018
General

Single-dose tafenoquine for radical cure of P. vivax malaria submitted for regulatory approval in Brazil

21 Sep 2018
Access & product management

Kozenis (tafenoquine) approved by the Australian Therapeutic Goods Administration for the radical cure of P. vivax malaria

21 Sep 2018
Access & product management

Severe malaria case fatality reduced by 96% in pilot project in Zambia led by Transaid, MMV and partners

28 Aug 2018
Access & product management

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria

20 Jul 2018
R&D, Access & product management

US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria

12 Jul 2018
R&D, Access & product management

MMV Project of the Year 2017 awarded to Sanofi

10 Jul 2018
R&D, Partner

Strides Shasun’s rectal artesunate product receives WHO prequalification

21 Jun 2018
Access & product management

MMV deeply saddened by the loss of Prof. Ogobara Doumbo

11 Jun 2018
General

Australia renews commitment to MMV and R&D for malaria

08 Jun 2018
Donors

MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018

30 Apr 2018
R&D

MMV’s contributions to malaria commended at MIM conference

27 Apr 2018
General

Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period

29 Mar 2018
R&D

WHO provides first-ever approval for rectal artesunate product for severe malaria

27 Feb 2018
Access & product management

MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF

14 Feb 2018
Donors

MMV and DNDi deliver joint statement at WHO Executive Board

27 Jan 2018
General

MMV end-of-year review 2017

02 Jan 2018
General

WHO issues information note on correct use of rectal artesunate for severe malaria

18 Dec 2017
Access & product management

Unitaid awards MMV new supply side grant

08 Dec 2017
Access & product management

PLOS Medicine publishes New Malaria Eradication Road Map

01 Dec 2017
R&D

Two new MMV-supported research sites inaugurated in Ethiopia

30 Nov 2017
R&D

Two MMV partners receive international award

30 Nov 2017
R&D

Global malaria response “off track” in 2016

29 Nov 2017
General

GSK submits US regulatory application for single-dose tafenoquine for Plasmodium vivax malaria

28 Nov 2017
R&D

USAID renews support to MMV with new grant

09 Nov 2017
General

100 million vials of injectable artesunate distributed since 2010

06 Nov 2017
Access & product management

MMV backs training course for study coordinators

01 Nov 2017
R&D

MMV and Transaid partner to tackle severe malaria in Zambia

31 Oct 2017
Access & product management

MMV hosts international drug discovery meeting in Geneva

26 Oct 2017
R&D

Three vivax research teams awarded MMV Project of the Year 2016

10 Oct 2017
General, R&D

MMV discovery partners receive ASBMB awards

09 Oct 2017
R&D

KAF156 enters phase IIb combination studies

21 Aug 2017
R&D

Everything you always wanted to know about malaria and more

03 Aug 2017
General, R&D

Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children

25 Jul 2017
Access & product management

Three MMV-supported antimalarials listed as essential medicines

16 Jun 2017
Access & product management

MMV and GSK announce positive headline phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria

12 Jun 2017
R&D

Dr Tedros Adhanom Ghebreyesus elected as the new Director-General of WHO

24 May 2017
General

MMV and partners launch “call to action” to G20 health ministers

22 May 2017
General

MMV launches new Severe Malaria Observatory

18 May 2017
General

MMV and Aga Khan Foundation Canada come together to tackle malaria in Mali

01 May 2017
Access & product management

New publication highlights efficacy of MMV048 against resistant strains of malaria

27 Apr 2017
R&D

New antimalarial compound treats and protects in a single dose

29 Mar 2017
R&D

MMV 4th in top 10 rare infectious disease drug developers

28 Mar 2017
General

Awa Marie Coll-Seck receives Best Minister Award

27 Feb 2017
General

MMV shines a light on malaria in Times Square

22 Feb 2017
General

RBM appoints new CEO

27 Jan 2017
General

MMV delivers statement at 140th session of the WHO Executive Board

27 Jan 2017
General

MMV welcomes the launch of the End Malaria Council

25 Jan 2017
General

MMV brings new partner Janssen Pharmaceuticals on board

19 Jan 2017
Partner

MMV end-of-year review 2016

22 Dec 2016
General

Swiss Malaria Group invites you to enter photo and video competition

17 Dec 2016
General

Pages